Fig. 1 · Structure
Documents & Downloads
β-CCM
Benzodiazepine Receptor Inverse Agonist
β-CCM is an inverse agonist at the benzodiazepine receptor, exhibiting anxiogenic and proconvulsant properties. It enhances emotional reactivity while diminishing susceptibility to interference in spatial working memory tasks. This compound is valuable for research focused on anxiety-related disorders and can help elucidate the mechanistic pathways involved in anxiety regulation.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inverse Agonist |
| CAS Number | 69954-48-9 |
| Applications | Benzodiazepine Receptor Inverse Agonist |
| Formula | C13H10N2O2 |
| Molecular Weight | 226.23 |
| Synonyms | Beta-CCM; Ro 22-7497 |
| SMILES | O=C(C1=CC2=C(C=N1)NC3=C2C=CC=C3)OC |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.